Nuclear Accumulation of Histone Deacetylase 4 (HDAC4) Coincides with the Loss of Androgen Sensitivity in Hormone Refractory Cancer of the Prostate
- 30 October 2003
- journal article
- Published by Elsevier in European Urology
- Vol. 45 (3) , 382-389
- https://doi.org/10.1016/j.eururo.2003.10.005
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2The EMBO Journal, 2003
- Expression of Tip60, an androgen receptor coactivator, and its role in prostate cancer developmentOncogene, 2003
- Regulation of FGF8 expression by the androgen receptor in human prostate cancerOncogene, 2002
- Translating the Histone CodeScience, 2001
- The Human Histone Deacetylase FamilyExperimental Cell Research, 2001
- Histone deacetylase 4 associates with extracellular signal-regulated kinases 1 and 2, and its cellular localization is regulated by oncogenic RasProceedings of the National Academy of Sciences, 2000
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Androgen regulation of the messenger RNA encoding diazepam-binding inhibitor/acyl-CoA-binding protein in the human prostatic adenocarcinoma cell line LNCaPMolecular and Cellular Endocrinology, 1994
- Brief, high‐temperature heat denaturation (pressure cooking): A simple and effective method of antigen retrieval for routinely processed tissuesThe Journal of Pathology, 1994
- Androgen receptors in endocrine‐therapy‐resistant human prostate cancerInternational Journal of Cancer, 1991